Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Neuberg

Showing results (291-300 of 354) with videos related to

Pageof 36
Sort By:
Frontiers in Immunology|January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor modelJ Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
Nature Nanotechnology|March 16, 2024
Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccinationYang C Zeng, Olivia J Young, Christopher M Wintersinger, et al.
Blood|June 17, 2022
TET2-mutant clonal hematopoiesis and risk of goutMridul Agrawal, Abhishek Niroula, Pierre Cunin, et al.
Cancer Cell|December 10, 2014
Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemiaDan A Landau, Kendell Clement, Michael J Ziller, et al.
Blood|August 29, 2018
A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigensZhuting Hu, Annabelle J Anandappa, Jing Sun, et al.
Science Translational Medicine|December 9, 2016
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissionsJacalyn Rosenblatt, Richard M Stone, Lynne Uhl, et al.
Cancer Cell|June 5, 2003
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative diseaseJan Cools, Elizabeth H Stover, Christina L Boulton, et al.
Transplantation and Cellular Therapy|April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated ToxicitiesTakuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.
Blood|April 30, 2014
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLLLili Wang, Alex K Shalek, Mike Lawrence, et al.
Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Pageof 36

Showing results (291-300 of 354) with videos related to

Sort By:
Pageof 36
Frontiers in Immunology|January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor modelJ Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
Nature Nanotechnology|March 16, 2024
Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccinationYang C Zeng, Olivia J Young, Christopher M Wintersinger, et al.
Blood|June 17, 2022
TET2-mutant clonal hematopoiesis and risk of goutMridul Agrawal, Abhishek Niroula, Pierre Cunin, et al.
Cancer Cell|December 10, 2014
Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemiaDan A Landau, Kendell Clement, Michael J Ziller, et al.
Blood|August 29, 2018
A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigensZhuting Hu, Annabelle J Anandappa, Jing Sun, et al.
Science Translational Medicine|December 9, 2016
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissionsJacalyn Rosenblatt, Richard M Stone, Lynne Uhl, et al.
Cancer Cell|June 5, 2003
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative diseaseJan Cools, Elizabeth H Stover, Christina L Boulton, et al.
Transplantation and Cellular Therapy|April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated ToxicitiesTakuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.
Blood|April 30, 2014
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLLLili Wang, Alex K Shalek, Mike Lawrence, et al.
Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Pageof 36